Jeremy Bender Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 month, 1 week ago
Jeremy Bender has an estimated net worth of at least $16.4 million*, as of Oct. 29, 2025. They own 177,165 shares of DAWN stock. They have sold 311,141 shares of DAWN stock since 2021, for an estimated $5.1 million.
Jeremy Bender $DAWN SEC Form 4 Insider Trading
Jeremy Bender has filed a total of 33 insider trades in $DAWN since 2021. Their most recent trade was a sale of 15,894 shares, made on Nov 17, 2025. Their largest trade was a sale of 70,051 shares, made on May 01, 2024. We estimate that they now own 177,165 shares of $DAWN, worth an estimated $11.3 million.
Insider Trading at $DAWN
There have been a total of 191 insider trades reported at $DAWN since 2021, with 6.5 million shares purchased and 3.9 million shares sold. The most active insider traders in $DAWN stock have been Samuel C. Blackman, Jeremy Bender, and Charles N Ii York. The most recent trade was a sale of 4,319 shares reported by Adam Dubow (Gen Counsel & Secretary), made on Nov 17, 2025.
History of Insider Stock Trades by Jeremy Bender
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
DAWN
|
Sale | 15,894 | Nov 17, 2025 | Nov. 18, 2025, 7:59 p.m. |
DAWN
|
Sale | 16,058 | Aug 18, 2025 | Aug. 19, 2025, 7:37 p.m. |
DAWN
|
Sale | 13,964 | May 16, 2025 | May 19, 2025, 5:44 p.m. |
DAWN
|
Sale | 12,048 | Feb 18, 2025 | Feb. 21, 2025, 7:05 p.m. |
DAWN
|
Sale | 10,554 | Nov 18, 2024 | Nov. 19, 2024, 5:36 p.m. |
DAWN
|
Sale | 10,681 | Aug 16, 2024 | Aug. 19, 2024, 5:53 p.m. |
DAWN
|
Sale | 7,873 | May 16, 2024 | May 17, 2024, 6:27 p.m. |
DAWN
|
Sale | 9,154 | May 03, 2024 | May 3, 2024, 6:48 p.m. |
DAWN
|
Sale | 70,051 | May 01, 2024 | May 3, 2024, 6:48 p.m. |
DAWN
|
Sale | 6 | May 02, 2024 | May 3, 2024, 6:48 p.m. |
DAWN
|
Sale | 7,615 | Feb 16, 2024 | Feb. 20, 2024, 7:14 p.m. |
DAWN
|
Sale | 3,107 | Nov 16, 2023 | Nov. 17, 2023, 7:20 p.m. |
DAWN
|
Sale | 2,996 | Aug 17, 2023 | Aug. 17, 2023, 6:16 p.m. |
DAWN
|
Sale | 3,104 | May 16, 2023 | May 17, 2023, 6:27 p.m. |
DAWN
|
Sale | 12,500 | Mar 07, 2023 | March 8, 2023, 6:50 p.m. |
DAWN
|
Sale | 3,022 | Feb 16, 2023 | Feb. 17, 2023, 6:26 p.m. |
DAWN
|
Sale | 12,500 | Jan 23, 2023 | Jan. 24, 2023, 6:11 p.m. |
DAWN
|
Sale | 12,500 | Dec 21, 2022 | Dec. 22, 2022, 6:50 p.m. |
DAWN
|
Sale | 400 | Nov 21, 2022 | Nov. 22, 2022, 7:43 p.m. |
DAWN
|
Sale | 12,100 | Nov 21, 2022 | Nov. 22, 2022, 7:43 p.m. |
DAWN
|
Sale | 1,513 | Nov 16, 2022 | Nov. 17, 2022, 6:33 p.m. |
DAWN
|
Sale | 12,500 | Nov 01, 2022 | Nov. 3, 2022, 5:30 p.m. |
DAWN
|
Sale | 12,500 | Oct 03, 2022 | Oct. 5, 2022, 4:22 p.m. |
DAWN
|
Sale | 10,641 | Sep 01, 2022 | Sept. 6, 2022, 7:50 p.m. |
DAWN
|
Sale | 1,859 | Sep 01, 2022 | Sept. 6, 2022, 7:50 p.m. |
DAWN
|
Sale | 10,641 | Sep 01, 2022 | Sept. 6, 2022, 7:49 p.m. |
DAWN
|
Sale | 1,859 | Sep 01, 2022 | Sept. 6, 2022, 7:49 p.m. |
DAWN
|
Sale | 4,003 | Aug 16, 2022 | Aug. 17, 2022, 7:24 p.m. |
DAWN
|
Sale | 12,500 | Aug 04, 2022 | Aug. 5, 2022, 5:19 p.m. |
DAWN
|
Sale | 2,600 | Jul 18, 2022 | July 20, 2022, 6:17 p.m. |
DAWN
|
Sale | 1,795 | Jul 08, 2022 | July 12, 2022, 7:30 p.m. |
DAWN
|
Sale | 1,746 | Jul 01, 2022 | July 6, 2022, 8:56 p.m. |
DAWN
|
Sale | 857 | Jul 05, 2022 | July 6, 2022, 8:56 p.m. |
$DAWN Executives and Stock Owners with Insider Trades
-
Samuel C. Blackman, Chief Medical Officer
-
Jeremy Bender, Chief Executive Officer
-
Charles N Ii York, COO, CFO and Secretary
-
Samuel C. Blackman, HEAD OF R&D
-
Jeremy Bender, CHIEF EXECUTIVE OFFICER
-
Charles N Ii York, COO, CFO AND SECRETARY
-
Adam Dubow, GENERAL COUNSEL
-
Lauren Merendino, Chief Commercial Officer
-
Adam Dubow, Gen Counsel & Secretary
-
Charles N Ii York, COO and CFO
-
Samuel C. Blackman, Head of Research and Developme
-
Adam Dubow, General Counsel
-
Samuel C. Blackman, HEAD OF RESEARCH AND DEVELOPME
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.